Skip navigation
FDA panel favors Pfizer's new arthritis drug
Federal health advisers said Wednesday that a first-of-a-kind drug from Pfizer appears to be safe and effective for patients with rheumatoid arthritis, though they recommended follow-up studies to gauge the pill's long-term side effects. Full story
More aging news
Nicotine patch may help improve memory, study finds
Senior moment? Nope, just thinking
Gay seniors fear housing discrimination
Elderly brains stay sharp after low trans-fat life
Obesity linked to older adults' risk of falls
At 100 years old, an Ohio doctor is still in
91-year-old yoga teacher: 'Why should I quit?'
Eating fish once a week may ward off Alzheimer's
Aging in place: Most in U.S. want to stay put
Census finds reaching age 90 more likely than ever
Want to live longer? Get happy, study says
X Prize contest seeks secrets in DNA of the elderly
NYT: A hearing aid that cuts out the clatter
Couple married 72 years die holding hands
Believing your health is bad hikes dementia risk
Time to shop: Some Medicare plan prices drop
Dementia patients suffer dubious hospitalizations
'Til death': Unless you have Alzheimer's?
Drugs used less often in treating dementia
Japan may soon lose top longevity ranking
Women may get unneeded osteoporosis screening
  Longevity secrets from 100-year-old doctor
Fat transfer for younger eyes may last 3 years
U.S. autopsy guidelines revised for Alzheimer's
Want to live forever? Scientist sees aging cured
  Alzheimer's disease  
  More   
Test teen football players for Alzheimer's gene?
First Alzheimer's prevention study launched
Device may spark memories in Alzheimer's patients
  Longevity
FDA panel favors Pfizer's new arthritis drug
Computer use and exercise may help fight memory loss
Emergency rooms designed for the older set 


Sponsored links

Resource guide